Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003825 · ClinicalTrials.gov registry record · Phase 3
Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
A Phase 3 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 174
- Enrollment target
NCT00003825 is a Phase 3 study that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 174 participants.
The verdict
NCT00003825, a Phase 3 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 174 participants
- Enrollment target
Study Summary
RATIONALE: Pentosan polysulfate may be effective in treating side effects of radiation therapy to the abdomen or pelvis. It is not yet known whether pentosan polysulfate is more effective than no further therapy for treating gastrointestinal disturbance caused by previous radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of pentosan polysulfate in treating patients who have inflammation of the rectum, diarrhea, or blood in stools caused by previous radiation therapy to the abdomen and pelvis.
Interventions
- PROCEDURE quality-of-life assessment
- DRUG pentosan polysulfate sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 1999-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003825
The ClinicalTrials.gov registry entry for NCT00003825 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which quality-of-life assessment is the first listed.
NCT00003825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003825 about?
NCT00003825 is a clinical study titled "Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy". RATIONALE: Pentosan polysulfate may be effective in treating side effects of radiation therapy to the abdomen or pelvis. It is not yet known whether pentosan polysulfate is more effective than no further therapy for treating gastrointestinal disturbance caused by previous radiation therapy. PURPOSE...
What is the current status of trial NCT00003825?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 174 participants. The study started on 1999-06.
What interventions are being tested in trial NCT00003825?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), pentosan polysulfate sodium (DRUG).
Who is sponsoring clinical trial NCT00003825?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.